Potiron, Vincent, 1980-....
Vincent A Potiron researcher
VIAF ID: 188631374 (Personal)
Permalink: http://viaf.org/viaf/188631374
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Design, synthesis and biological evaluation of 1,4-benzodiazepine-2,5-dione-based HDAC inhibitors. | |
Impact du microenvironnement et de la vascularisation tumorale dans la réponse de l'ostéosarcome à la chimiothérapie | |
Influence of Radiotherapy Fractionation Schedule on the Tumor Vascular Microenvironment in Prostate and Lung Cancer Models | |
Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition | |
A new tissue segmentation method to calculate 3D dose in small animal radiation therapy. | |
Non-coding RNAs in tumor progression and resistance. | |
Optimizing radiotherapy protocols using computer automata to model tumour cell death as a function of oxygen diffusion processes | |
Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions. | |
Reoxygenation during radiotherapy in intermediate-risk prostate cancer | |
Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. | |
Semaphorins and their receptors in lung cancer. | |
Study of the molecular mechanisms responsible for the anti-tumorigenic function of the semaphorin SEMA3F in lung cancer. | |
Tumor vasculature remodeling by radiation therapy increases doxorubicin distribution and efficacy | |
Validation of the analytical irradiator model and Monte Carlo dose engine in the small animal irradiation treatment planning system µ-RayStation 8B | |
ZEB1-responsive genes in non-small cell lung cancer |